Dianthus Therapeutics (DNTH) Amortization - Intangibles (2024 - 2025)
Dianthus Therapeutics (DNTH) recorded quarterly Amortization - Intangibles of $2.3 million in Q3 2025, up 110.47% quarter-over-quarter from $1.1 million in Q2 2025, and down 1.28% on a YoY basis from $2.3 million in Q3 2024.
Dianthus Therapeutics (DNTH) Amortization - Intangibles (2024 - 2025) Analysis & Trends
Dianthus Therapeutics' Amortization - Intangibles history runs 2 years deep, the most recent figure standing at $2.3 million for Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Dianthus Therapeutics | 3.60 Bn | 3.19 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 2.31 Mn |
| Jun 30, 2025 | 1.10 Mn |
| Mar 31, 2025 | 1.90 Mn |
| Sep 30, 2024 | 2.34 Mn |
| Jun 30, 2024 | 422,000.00 |
| Mar 31, 2024 | 518,000.00 |